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Abstract 
 
Onychocryptosis (ingrown nails) is the most common of pedal foot maladies seen 
by podiatrists (Armstrong et al., 2000) and makes up 3-5% of all foot problems. 
This condition is characterized by the nail plate growing into and cutting the 
lateral nail fold. Symptoms include erythema (redness) of the lateral nail fold, 
oedema (swelling) of the lateral nail fold and tenderness to pressure (Zuber, 
2002).  
 
Within the Materia Medica, the homoeopathic remedy Magnetis Polus Australis is 
indicated for the treatment of the symptom of “ingrowing toenail” (Vermeulen, 
1997). Although used for nearly 200 years, no research has been conducted to 
verify this claim. 
 
The study aimed at determining whether Magnetis Polus Australis in the 7th and 
30th centesimal potencies is effective in treating the symptoms of onychocryptosis 
of the hallux such as pain, tenderness to pressure, oedema and erythema. 
 
The study, a double-blind placebo study, involved thirty participants. The placebo 
group included ten participants and the experimental group included twenty 
participants, ten of which received the 7CH and the other ten received the 30CH.  
Each group took the homoeopathic or placebo medication orally twice daily for a 
period of three weeks. The participants were followed-up with an assessment 
questionnaire every two weeks for a one month period. At the end of the research 
period these questionnaires with the data were collected and statistically analyzed 
using chi-squared tests. 
 
The study indicated that Magnetis Polus Australis has a positive effect in the 
treatment of onychocryptosis of the hallux and has demonstrated effectiveness in 
reducing inflammation associated with it. Overall the 30th centesimal potency 
shows the highest percentage of improvement in the symptoms of 
onychocryptosis, though the percentages between the two experimental groups 
were very close. Further research using a larger research sample group is required 
to confirm these initial findings. 
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